Thermo Fisher Scientific Inc. (TMO) Q1 2026 (USD): EPS 5.44 (exp. 5.25), revenue 11.01bln (exp. 10.87bln)

Thermo Fisher Scientific's Q1 2026 results beat consensus on both EPS and revenue, which suggests strong demand and effective cost management.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

Netflix (NFLX) has authorised a buyback of an additional USD 25bln of shares

SpaceX sees bigger market opportunity within AI than in space, filing

Thermo Fisher Scientific Inc. (TMO) Q1 2026 (USD): EPS 5.44 (exp. 5.25), revenue 11.01bln (exp. 10.87bln)

Tesla (TSLA) to add 1,000 jobs in Germany by end-June, increase German Model Y output by 20% from Q3, hire hundreds for battery cell operations; moves are a response to Model Y demand, according to Reuters

UKMTO says it received a report of an incident 83 nautical miles southeast of Eyl, Somalia

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • GAAP operating margin 16.9% (prev. 16.6% Y/Y)
Context

This performance could impact investor sentiment positively, potentially lifting the stock and increasing interest in related sectors like pharmaceuticals and life sciences. Furthermore, the improvement in operating margin indicates enhanced efficiency, which may bode well for future profitability and valuation.

Related headlines

The whole workspace, free to try.

Try it free